BCL6 and non-small cell lung carcinoma: In three of the cell lines (A431, HCC827, and H1869), the BCL6 protein level gradually increased after gefitinib treatment indicating that the findings in A431 cells were true also in some NSCLC cells (Fig. 5A and supplemental Fig. S11A).